0001910489-22-000001.txt : 20220406 0001910489-22-000001.hdr.sgml : 20220406 20220405174813 ACCESSION NUMBER: 0001910489-22-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20220406 DATE AS OF CHANGE: 20220405 EFFECTIVENESS DATE: 20220406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Altera Good Growth Venture PA, LLC CENTRAL INDEX KEY: 0001910489 IRS NUMBER: 873468485 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-433586 FILM NUMBER: 22808460 BUSINESS ADDRESS: STREET 1: 10 GLENLAKE PARKWAY NE STREET 2: NORTH TOWER, SUITE 1020 CITY: ATLANTA STATE: GA ZIP: 30328 BUSINESS PHONE: 404-537-2759 MAIL ADDRESS: STREET 1: 10 GLENLAKE PARKWAY NE STREET 2: NORTH TOWER, SUITE 1020 CITY: ATLANTA STATE: GA ZIP: 30328 D/A 1 primary_doc.xml X0708 D/A LIVE 0001910489 Altera Good Growth Venture PA, LLC 10 GLENLAKE PARKWAY NE NORTH TOWER, SUITE 1020 ATLANTA GA GEORGIA 30328 404-537-2759 DELAWARE None None Limited Liability Company true 2021 N/A Altera Good Growth Venture PA GP, LLC 10 Glenlake Parkway NE North Tower, Suite 1020 Atlanta GA GEORGIA 30328 Executive Officer Managing Member of the Issuer Mitch Reiner 10 Glenlake Parkway NE North Tower, Suite 1020 Atlanta GA GEORGIA 30328 Executive Officer Member of the Managing Member of the Issuer N/A Altera Private Access, LLC 10 Glenlake Parkway NE North Tower, Suite 1020 Atlanta GA GEORGIA 30328 Executive Officer Investment Manager of the Issuer David Fershteyn 10 Glenlake Parkway NE North Tower, Suite 1020 Atlanta GA GEORGIA 30328 Executive Officer Member of the Managing Member of the Issuer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.1 true 0001910480-22-000002 2022-01-31 false true true false 200000 6175000 6175000 0 false 21 0 true 0 true 250000 true false Altera Good Growth Venture PA, LLC Tim Partridge Tim Partridge Authorized Signatory, Head of Research 2022-04-05